» Articles » PMID: 29445150

Loss of NDRG2 in Liver Microenvironment Inhibits Cancer Liver Metastasis by Regulating Tumor Associate Macrophages Polarization

Overview
Journal Cell Death Dis
Date 2018 Feb 16
PMID 29445150
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The liver is the predominant metastatic site for several types of malignancies. Tumor-associated macrophages (TAMs) in the liver play crucial roles in the metastasis process. Shifting tumor-promoting M2-like TAMs toward the M1-like phenotype, which exerts tumor suppressor functions via phagocytosis and the secretion of inhibitory factors, may be a potential therapeutic strategy for liver cancer metastasis treatment.We first cloned NDRG2 (N-myc downstream-regulated gene 2) and verified its tumor suppressor role in multiple solid tumors, including colorectal cancer and hepatocellular carcinoma. However, its role in the tumor-associated liver microenvironment, especially in TAMs, has not been illustrated. By establishing a liver cancer metastasis model in wild-type (WT) and Ndrg2 knockout (Ndrg2-/-) mice, we found that the loss of the tumor suppressor Ndrg2 in liver microenvironment significantly suppressed the growth of liver colonies. In addition, this process was accompanied by a higher proportion of M1-like TAM infiltration in Ndrg2-/- mice. Interestingly, bone marrow (BM) transplantation revealed that BM-derived macrophages (BMDMs) rather than liver resident Kupffer cells were responsible for the inhibitory effect. We further demonstrated that loss of Ndrg2 influenced TAM polarization via the NF-κB pathway. Inhibition of IκBα phosphorylation in cancer cell-conditioned medium-stimulated BMDMs decreased M1 marker expression in Ndrg2-/- macrophages. Finally, in vitro, invasion, migration, and proliferation assays confirmed that NF-κB participated in the tumor suppressor function of Ndrg2-/- macrophages. Collectively, our findings highlight the role of NDRG2 in the regulation of TAM polarization and its function in promoting cancer liver metastasis.

Citing Articles

Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis.

Li S, Hao L, Hu X J Inflamm Res. 2024; 17:8429-8443.

PMID: 39529996 PMC: 11552512. DOI: 10.2147/JIR.S493656.


Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients.

Mestareehi A, Abu-Farsakh N ACS Omega. 2024; 9(9):10299-10331.

PMID: 38463290 PMC: 10918787. DOI: 10.1021/acsomega.3c07787.


NF-κB: Governing Macrophages in Cancer.

Cornice J, Verzella D, Arboretto P, Vecchiotti D, Capece D, Zazzeroni F Genes (Basel). 2024; 15(2).

PMID: 38397187 PMC: 10888451. DOI: 10.3390/genes15020197.


Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.

Tang W, Sun G, Ji G, Feng T, Zhang Q, Cao H J Immunother Cancer. 2023; 11(11).

PMID: 38007237 PMC: 10679975. DOI: 10.1136/jitc-2023-007030.


Impact of immune tolerance mechanisms on the efficacy of immunotherapy in primary and secondary liver cancers.

Sankar K, Pearson A, Worlikar T, Perricone M, Holcomb E, Mendiratta-Lala M Transl Gastroenterol Hepatol. 2023; 8:29.

PMID: 37601739 PMC: 10432235. DOI: 10.21037/tgh-23-11.


References
1.
Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S . Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol. 2010; 53(5):903-10. DOI: 10.1016/j.jhep.2010.04.037. View

2.
Saccani A, Schioppa T, Porta C, Biswas S, Nebuloni M, Vago L . p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006; 66(23):11432-40. DOI: 10.1158/0008-5472.CAN-06-1867. View

3.
Watari K, Shibata T, Nabeshima H, Shinoda A, Fukunaga Y, Kawahara A . Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci Rep. 2016; 6:19470. PMC: 4726041. DOI: 10.1038/srep19470. View

4.
Yang M, Shao J, Miao Y, Cui W, Qi Y, Han J . Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization. Cell Death Differ. 2014; 21(8):1290-302. PMC: 4085533. DOI: 10.1038/cdd.2014.45. View

5.
Tamura T, Ichikawa T, Nakahata S, Kondo Y, Tagawa Y, Yamamoto K . Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential. Cancer Res. 2017; 77(9):2363-2374. DOI: 10.1158/0008-5472.CAN-16-2114. View